<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Hongda Zhao</author>
     <author>Kang Liu</author>
     <author>Alfonso Crisci</author>
     <author>Ed te Slaa</author>
     <author>Tomonori Habuchi</author>
     <author>Murat Akand</author>
     <author>Chi Fai Ng</author>
     <author>Pilar Laguna</author>
     <author>Jeremy Yuen-Chun Teoh</author>
     <author>Jean de la Rosette</author>
    </authors>
   </contributors>
   <titles>
    <title>Impact of smoking status at diagnosis on oncological outcomes of upper-tract urothelial carcinoma</title>
   </titles>
   <keywords>
    <keyword>oncological outcomes</keyword>
    <keyword>recurrence</keyword>
    <keyword>smoking</keyword>
    <keyword>upper tract urothelial carcinoma</keyword>
    <keyword>Scopus</keyword>
    <keyword>Web of Science</keyword>
    <keyword>Белый список</keyword>
   </keywords>
   <dates>
    <year>2025</year>
    <pub-dates>
     <date>2026-06-16</date>
    </pub-dates>
   </dates>
   <doi>10.1177/17562872251352049</doi>
   <journal>THERAPEUTIC ADVANCES IN UROLOGY</journal>
   <abstract>Background: The evidence supporting personalized surveillance strategies for upper-tract&#13;
urothelial carcinoma (UTUC) remains limited. This study seeks to explore how smoking habits&#13;
influence the oncological outcomes of UTUC&#13;
Methods: Data on disease characteristics from UTUC patients were gathered prospectively.&#13;
Recurrence-free survival was the primary outcome measured. Patients were stratified based&#13;
on smoking status for Kaplan–Meier and multivariable Cox regression analyses.&#13;
Results: A total of 1952 patients were involved, including 684 (35%) patients who never&#13;
smoked, 572 (29%) that were ex-smokers, and 696 (36%) that were current smokers. For&#13;
female patients, most of them were nonsmokers (n= 328). Current smokers were significantly&#13;
younger and had higher American Society of Anesthesiologist (ASA) scores and Charlson&#13;
Comorbidity Index. A total of 19.9% (n = 236) of patients developed tumor recurrence.&#13;
Kaplan–Meier analyses showed that smoking status was associated with a greater likelihood&#13;
of urothelial carcinoma recurrence (p = 0.011) and intravesical recurrence (p = 0.021). The&#13;
multivariable Cox regression analysis identified the smoking status as an independent&#13;
risk factor for urothelial carcinoma recurrence (p = 0.046). When compared with former&#13;
smokers, current smokers showed a higher urothelial carcinoma recurrence (p = 0.016) and&#13;
intravesical recurrence (p = 0.006).&#13;
Conclusion: Smoking at the time of diagnosis was significantly associated with an increased&#13;
risk of tumor recurrence in the bladder but not significantly in the upper urinary tract. This&#13;
study confirms that cumulative smoking exposure accelerates the risk of tumor recurrence&#13;
and underlines the importance of smoking cessation.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/5528</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/5722</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
